Page last updated: 2024-11-02

piribedil and Hallucination of Body Sensation

piribedil has been researched along with Hallucination of Body Sensation in 3 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kölle, M1
Lepping, P1
Kassubek, J1
Schönfeldt-Lecuona, C1
Freudenmann, RW1
Tan, EK1
Ratnagopal, P1
Han, SY1
Wong, MC1
Angrist, B1
Thompson, H1
Shopsin, B1
Gershon, S1

Trials

1 trial available for piribedil and Hallucination of Body Sensation

ArticleYear
Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study.
    Acta neurologica Scandinavica, 2003, Volume: 107, Issue:3

    Topics: Administration, Oral; Aged; Antiparkinson Agents; Bromocriptine; Cross-Over Studies; Female; Halluci

2003

Other Studies

2 other studies available for piribedil and Hallucination of Body Sensation

ArticleYear
Delusional infestation induced by piribedil add-on in Parkinson's disease.
    Pharmacopsychiatry, 2010, Volume: 43, Issue:6

    Topics: Antiparkinson Agents; Delusions; Drug Therapy, Combination; Ectoparasitic Infestations; Female; Hall

2010
Clinical studies with dopamine-receptor stimulants.
    Psychopharmacologia, 1975, Nov-21, Volume: 44, Issue:3

    Topics: Adult; Apomorphine; Blood Pressure; Dopamine; Female; Hallucinations; Humans; Male; Metoclopramide;

1975